short-term co-administration of acid folicfor treating children and adolescents with autism
Phase 2
- Conditions
- Pervasive developmental disorders.Childhood autism
- Registration Number
- IRCT201402043930N33
- Lead Sponsor
- Vice chancellor for research, Shiraz University of Medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Autism according to DSM-IV diagnostic criteria; aged 3 to 19 years old.
Exclusion Criteria
primary diagnosis of a psychotic disorder; active substance abuse or dependence; unstable medical condition.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Irritability. Timepoint: Every 4 weeks. Method of measurement: Abbrant Behavior Checklist.
- Secondary Outcome Measures
Name Time Method Adverse effects. Timepoint: Week 2, 4, and 8. Method of measurement: checklist.